资讯

Value chain analysis is an investigation of a business's value chain, the full range of activities a company conducts to create a product or a service. The purpose of value-chain analysis is to ...
Extreme Conditions Physics Research Laboratory and Center of Excellence in Physics of Energy Materials (CE:PEM), Department of Physics, Faculty of Science, Chulalongkorn University, Bangkok 10330, ...
C2N Diagnostics LLC said that Samsung C&T Corp ... "contributed to the stabilization of the biopharmaceutical supply chain" and made high quality pharmaceuticals easier to access, Jaywoo Kim ...
C2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said the cash injection would help to scale its clinical laboratory ...
Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an FDA-approved PD-L1 inhibitor. Japan's Ono Pharmaceutical bought an antisense ...
C2N is currently expanding its biomarker pipeline by developing advanced assays targeting tau pathology, Parkinson’s disease research, and developing technologies to decentralize mass spectrometry ...
it has contributed to the stabilization of the biopharmaceutical supply chain and better access to high quality bio pharmaceutics. The investment into C2N Diagnostics shows Samsung’s continued ...
Samsung C&T announced Thursday that its Life Science Fund, established in collaboration with Samsung Biologics, Samsung Bioepis and Samsung Venture Investment, will invest $10 million in C2N ...
Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics ... to the stabilization of the biopharmaceutical supply chain and better access to high quality bio pharmaceutics ...
Samsung C&T announced on the 13th that it will invest $10 million (about 14.5 billion won) in C2N Diagnostics in the United States through a life sciences fund established with its subsidiaries ...